relative to the practice of pharmacy, the dispensing of certain medications by pharmacists, and permitting treatment of certain severe illness under the right to try act.

The header text was changed from 'AS AMENDED BY THE SENATE' to 'VERSION ADOPTED BY BOTH BODIES', indicating the bill has passed both chambers.

Added authority for licensed health care professionals to dispense up to a 30-day supply of noncontrolled oral anti-cancer medications.

Authorized licensed advanced pharmacy technicians to engage in remote processing of medications.

Allowed supervised certified pharmacy technicians to administer vaccines, removing previous requirements for CDC Advisory Committee approval before administration.

Removed the requirement that a pharmacist's name or initials must appear on labels for controlled drugs or prescriptions.

Limited examination requirements for advanced pharmacy technician licensure to the scope of practice and prohibited testing on pharmacy jurisprudence.

Amended the legal definition of the 'practice of pharmacy' to reflect new dispensing and technician roles.

Removed the board of pharmacy's authority to regulate collaborative pharmacy practice agreements.

The definition of 'individualized investigational treatment' was updated to remove references to specific deleted treatment types (like certain gene therapies or vaccines) that were previously struck through, leaving a cleaner list of examples.

Formatting and indentation were corrected throughout the document, including the header information and the list of protected access types, to ensure consistency with the amended version.